Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: Insights from the ODYSSEY OUTCOMES trial
- Rafael Diaz
- , Qian H. Li
- , Deepak L. Bhatt
- , Vera A. Bittner
- , Marie T. Baccara-Dinet
- , Shaun G. Goodman
- , J. Wouter Jukema
- , Takeshi Kimura
- , Alexander Parkhomenko
- , Robert Pordy
- , Zeljko Reiner
- , Matthew T. Roe
- , Michael Szarek
- , Hung Fat Tse
- , Harvey D. White
- , Doron Zahger
- , Andreas M. Zeiher
- , Gregory G. Schwartz
- , Ph Gabriel Steg
Research output: Contribution to journal › Article › peer-review
55
Scopus
citations